Our VP R&D, Dr. Shiri Meshner, will be presenting at the Pharmabiotics 2023 Conference, “The Future of Microbiome-based Medicines”, taking place in Lyon, France from March 21-22, 2023.
The results demonstrate the efficacy of Biomica’s live bacterial consortia, BMC426 and BMC427, for the treatment of IBS
Today announced it will be in attendance at the Healthcare Week taking place together with the J.P. Morgan Healthcare Conference in San Francisco. The conference is one of the industry’s largest conferences of the year.
The results demonstrate the efficacy of Biomica’s live bacterial consortia, BMC426 and BMC427, for the treatment of IBS
